PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.
'Pharmacies propose a challenge but also an opportunity. If we ignore them, we ignore the health needs of a very large group of patients.' Millicent Olulo Orera
On the second day of the SafeCare conference ‘Quality in practice: towards sustainable quality of care in Africa’ the newly developed Pharmacy Improvement Program was introduced. The presentation, which was given by Millicent Olulo Orera, Senior Quality Manager of SafeCare in Kenya, addressed the scope of the program, the challenges and the need. It was real food for thought for the health experts present at the conference and evoked a lively discussion.
The Pharmacy Improvement Program aims to improve access to quality medicines through enhancing quality and finance in private pharmacies. Put simply it is an extension of the Medical Credit Fund and SafeCare program that thus far focused on improving the quality and financial situation of clinics only. As pharmacies play an important role in the provision of healthcare, it was decided to expand the program to pharmacies.
The development of the pharmacy program was supported by the expertise of the Pfizer Global Health Fellows (GHF). The GHF program is Pfizer’s signature international corporate volunteer program which places its highly skilled colleagues in three to six month specialized fellowships with leading international health organizations. Through this partnership a strategy on how to go about increasing the quality of services and the bankability of small private pharmacies was developed, and also presented by Miss Orera.
The presentation was followed by a lively discussion on for instance how to address the pharmacies retailers without addressing the wholesalers, how to ensure the quality of care beyond stocks and how to identify counterfeit drugs in the program. ”The program is definitely work in progress,” explained Miss Orera. ”We want to start with the loan program and in time see how we can work with retailers and wholesalers to control the supply of medicines and prevent counterfeit and substandard drugs from entering the pharmacies as much as possible.”
Another frequently heard concern during the session was the fact that unregistered pharmacies far outnumber registered pharmacies, yet are excluded from the program. Miss Orera acknowledged that this will be a challenge since there are many unregistered pharmacies and these are often the first point of contact for customers. ”The program will only include pharmacies that have appropriate registration and qualifications. If we can encourage pharmacies to register their premises, that’s a plus as we ensured that they operate within the regulatory framework. We’ll be working closely with the regulators to manage this and will not lock out pharmacies in the remote and rural areas.”
In Africa, about 50 percent of the people turn to their local pharmacy or drug seller for advice when ill. Yet, many of the drug sellers are unregistered and unqualified and services can be of poor quality. Medicines are not always available, too expensive or of unreliable quality. And pharmacies lack access to finance to improve the situation.
Please click here for an overview of the program
